Archive: 25/08/2022
Swiss drugmaker Novartis to spin off generics unit Sandoz
Swiss pharmaceuticals company Novartis said Thursday that it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year.
Aug 25, 2022